FIELD: medical biotechnology.
SUBSTANCE: invention relates to the field of medical biotechnology and concerns a method for determining genetic markers of polygenic risk of breast cancer (hereinafter – BC). A method for analyzing 38 genetic markers for assessing the polygenic risk of developing hormone-negative and hormone-positive subtypes of BC is proposed: 11q13.1 (rs3903072), 12q24 (rs12920U), 19q13.31 (rs3760982), 2q14.2 (rs4849887), 2q35 (rs16857609, rs13387042), 6q14.1 (rs17529111), 8p21.1 (rs9693444), 8q21.11 (rs6472903), 8q24.21 (rs11780156), BRCA2 (rs11571833), CASP8 (rs1045485), CCND1 (rs78540526), CDCA7 (rs1550623), CDKN2A/B (rs1011970), CHEK2 I157T (rs17879961), DNAJC1 (rs11814448), EBF1 (rs1432679), ESR1 (rs12662670, rs2046210), FGFR2 (rs2981579), FOXQ1 (rs11242675), FTO (rs17817449), HNF4G (rs2943559), LSP1 (rs3817198), MKL1 (rs6001930), NTN4 (rs17356907), PDE4D (rs1353747), PEX14 (rs616488), PTHLH (rs10771399), RAB3C (rs10472076), RAD51L1 (rs999737), SSBP4 (rs4808801), TCF7L2 (rs7904519), TERT (rs2736108, rs7726159), TOX3 (rs3803662), ZNF365 (rs10995190).
EFFECT: invention allows simultaneous determination of genotypes at selected loci using multiplex PCR and subsequent hybridization with an oligonucleotide biological microchip (biochip).
2 cl, 2 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING GENETIC MARKERS FOR ASSESSING POLYGENIC RISK OF DEVELOPING HORMONE-POSITIVE SUBTYPE OF BREAST CANCER | 2020 |
|
RU2753002C1 |
| METHOD FOR DETECTING GENETIC RISK FACTORS FOR DEVELOPMENT OF ALZHEIMER TYPE DEMENTIA ON THE BASIS OF HYDROGEL MATRIX BIOCHIP | 2022 |
|
RU2795795C1 |
| METHOD FOR DETERMINING POLYMORPHIC MARKERS IN SLCO1B1, APOE AND ABCB1 GENES FOR DETERMINING INDIVIDUAL SENSITIVITY TO STATINS | 2018 |
|
RU2695783C1 |
| METHOD OF ANALYZING TERMINAL MUTATIONS IN BRCA1, BRCA2, ATM AND PALB2 GENES USING MULTIPLEX PCR AND SUBSEQUENT HYBRIDISATION WITH AN OLIGONUCLEOTIDE BIOLOGICAL MICROCHIP (BIOCHIP) | 2020 |
|
RU2729360C1 |
| SET OF OLIGONUCLEOTIDE PRIMERS AND PROBES FOR GENETIC TYPING OF POLYMORPHOUS DNA LOCI ASSOCIATED WITH A RISK OF PROGRESSION OF SPORADIC FORM OF ALZHEIMER'S DISEASE IN RUSSIAN POPULATIONS | 2014 |
|
RU2600874C2 |
| METHOD FOR ANALYSING GENETIC POLYMORPHISM FOR DETERMINING DISPOSITION TO SCHIZOPHRENIA AND ALCOHOLISM | 2012 |
|
RU2565036C2 |
| METHOD FOR IDENTIFICATION OF GENETIC POLYMORPHISMS AFFECTING METABOLISM OF ANTICANCER DRUGS USING BIOLOGICAL MICROCHIPS | 2018 |
|
RU2697096C1 |
| METHOD FOR GENETIC POLYMORPHISM RAPID ANALYSIS FOR DETECTION OF GENETIC PREDISPOSITION TO BREAST CANCER | 2014 |
|
RU2617936C2 |
| METHOD FOR ANALYSIS OF SOMATIC MUTATIONS IN PI3K GENE USING LNA-BLOCKING MULTIPLEX PCR AND SUBSEQUENT HYBRIDISATION WITH OLIGONUCLEOTIDE BIOLOGICAL MICROCHIP (BIOCHIP) | 2013 |
|
RU2549682C1 |
| SET OF DIFFERENTIATING NUCLEOTIDES AND BIOCHIP APPLICABLE IN METHOD FOR GENETIC TYPING OF HUMAN Y-CHROMOSOMES HAPLOGROUP MARKERS: M130 (C), M145 (DE) | 2012 |
|
RU2539733C2 |
